Blood and Fluid Warmer Market (By Application: Homecare, Acute Care, Newborn Care, Preoperative Care, Others; By Product: Patient Warming Accessories, Intravenous Warming System, Surface Warming System; By End-user: Clinics, Hospitals, Specialty Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global blood and fluid warmer market size was valued at USD 1.15 billion in 2023 and is anticipated to reach around USD 2.35 billion by 2033, growing at a CAGR of 7.40% from 2024 to 2033. The aging population and childbirth are driving incessant growth, which will drive the growth of the blood and fluid warmer market over the forecast period.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
A blood warmer is a device used to heat blood or fluids before transfusion, ensuring they reach a temperature safe for infusion. This device is particularly utilized in ICUs, hospitals, clinics, and operating rooms to prevent hypothermia. Hypothermia can result from medical complications such as diabetes, thyroid conditions, severe trauma, and drug or alcohol abuse. Blood warmers feature enhanced accessibility, portability, and patient comfort. Additionally, the increasing average life expectancy is a key factor driving the blood fluid warming system market. Even moderate environments can cause hypothermia, depending on factors like age, overall metabolism, body mass, and duration of exposure to cold climates.
Report Coverage | Details |
Blood and Fluid Warmer Market Size in 2023 | USD 1.15 Billion |
Blood and Fluid Warmer Market Size in 2024 | USD 1.23 Billion |
Blood and Fluid Warmer Market Size by 2033 | USD 2.35 Billion |
Blood and Fluid Warmer Market Growth Rate | CAGR of 7.40% from 2024 to 2033 |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Application, Product, End-user, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Increasing the number of surgical interventions
The global blood and fluid warmer market is expected to grow due to the rising number of surgical interventions worldwide. The increasing prevalence of patients with various medical conditions, including life-threatening issues, along with greater access to medical care as global healthcare expenditure rises, are key factors driving higher consumption of blood and fluid warmers.
Additionally, a sedentary lifestyle, poor dietary choices, excessive consumption of unhealthy food, frequent smoking, and alcohol intake contribute to a higher risk of cardiovascular diseases (CVDs). Blood and fluid warmers are not limited to surgical centers; they are also extensively used in trauma units. The growing number of accidents, incidents, and injuries caused by various external factors has led to an increased use of warmers in trauma units.
Financial constraints faced by healthcare institutions, particularly in developing regions, can create a significant challenge to the growth of the blood and fluid warmer market. Limited financial resources can hinder the wider implementation of blood fluid warming systems despite considerable interest in advanced medical technologies. Moreover, the complexity of healthcare regulatory frameworks also creates challenges for manufacturers and healthcare institutions attempting to integrate these systems into their standard operating procedures.
Opportunity: Increasing demand for portable blood/IV fluid warmers
The blood and fluid warmer market expansion for portable blood/IV fluid warmers is anticipated to be driven by increased usage by hospitals, EMS crews, and the military to prevent hypothermia during fluid transfer in hazardous field settings. Unlike non-portable versions, portable blood warmers do not need an external power source and typically weigh less than 1 kg, including batteries and additional accessories, which makes them ideal for field use by EMS providers. These factors are likely to stimulate growth in the portable warmer market soon.
Moreover, increasing R&D activities by scientists to enhance physicians' understanding of blood warmers positively impacts market growth. Research initiatives aimed at developing safe and effective methods to improve blood transfusions are expected to create opportunities for market growth over the forecast period.
The acute care segment dominated the blood and fluid warmer market share in 2023. This pertains to medical procedures for urgent conditions, severe injuries, illnesses, or during the postoperative recovery phase. The rising number of accident cases and increasing patient admissions in trauma care centers have driven significant growth in this segment. Additionally, growing investments in constructing well-equipped EMS units are expected to support future growth.
The homecare segment is expected to show the fastest growth in the blood and fluid warmer market over the forecast period. These services aim to enhance the patient's health and well-being, foster independence and self-care, and reduce the necessity for hospitalizations or long-term care facility visits. By managing their health conditions at home, older adults can avoid unnecessary hospital visits. Home health care in the context of blood monitoring provides regular check-ups and education. Patients also have 24/7 access to a professional for guidance when experiencing troubling symptoms and uncertainty about their next steps.
The hospitals segment dominated the blood and fluid warmer market in 2023. Hospital institutions dominate the blood/IV warmers market, serving most of the population at any time. Hospitals are the largest consumers of IV and blood infusion products and services. Due to their long-term agreements with suppliers of blood-IV warming machines, hospitals possess significant negotiating power, making them a key market for product after-sales services. Additionally, the increasing rate of hospitalizations driven by the rise in trauma cases and infectious diseases, the proliferation of advanced and well-equipped hospitals, the aging population, and the growing prevalence of chronic illnesses are expected to fuel segment growth.
The specialty centers segment is projected to show the fastest growth during the forecast period. The demand for specialized inpatient and outpatient care has been increasing. Specialty hospitals play a crucial role in treating patients requiring specific care by offering high-quality care and safety while enhancing access. These institutions contribute to improved functional independence, reduced medical complications, relevant education and resources, and increased productivity.
North America dominated the blood and fluid warmer market in 2023. North America is poised to experience the highest growth in the global blood and fluid warmer market, driven by the widespread adoption of these devices in the region's healthcare sector. The presence of numerous players focusing on research and development to enhance device performance, combined with the availability of skilled medical professionals, is expected to stimulate regional growth.
The U.S. healthcare industry also operates under stringent quality guidelines, with established protocols shaping the country’s medical care sector. The increasing rate of U.S. Food and Drug Administration (FDA) approvals and the entry of new market players have significantly propelled growth in North America.
Asia Pacific is expected to host the fastest-growing blood and fluid warmer market throughout the forecast period. Asia Pacific is poised to witness significant growth in the global blood and fluid warmer market, driven by several factors. A large patient population and increasing demand for advanced yet cost-effective healthcare solutions are expected to create substantial growth opportunities in the region. Furthermore, global players are making high investments in research and development to tap into untapped markets in Asia Pacific, leveraging its low-cost services and conducive clinical trial environment. Moreover, the region is experiencing an uptick in hospitalizations and advancements in the clinical development framework of developing nations, which further supports market growth.
Segments Covered in the Report
By Application
By Product
By End-user
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood and Fluid Warmer Market
5.1. COVID-19 Landscape: Blood and Fluid Warmer Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood and Fluid Warmer Market, By Application
8.1. Blood and Fluid Warmer Market Revenue and Volume, by Application, 2024-2033
8.1.1 Homecare
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Acute Care
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Newborn Care
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Preoperative Care
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Blood and Fluid Warmer Market, By Product
9.1. Blood and Fluid Warmer Market Revenue and Volume, by Product, 2024-2033
9.1.1. Patient Warming Accessories
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Intravenous Warming System
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Surface Warming System
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Blood and Fluid Warmer Market, By End-user
10.1. Blood and Fluid Warmer Market Revenue and Volume, by End-user, 2024-2033
10.1.1. Clinics
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Specialty Centers
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Blood and Fluid Warmer Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 12. Company Profiles
12.1. The 37 Company (37°C)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Smiths Medical
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Enthermics Medical Systems
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Becton
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Dickinson and Company (BD)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. The 41st Parameter
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. 3M Healthcare
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Gambro
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Stihler Electronic GmbH
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. di Barkey GmbH & Co. KG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client